AU
UK
CA
NZ
IND
US
SkyWater Technology (Nasdaq: SKYT)has completed the acquisition of Infineon Technologies AG’s 200 mm semiconductor fabrication facility in Austin, Texas, known as Fab 25, for a total upfront consideration of approximately USD 93 million. The transaction includes a USD 73 million closing payment and an …
Progress Software (Nasdaq: PRGS)has announced the acquisition of Nuclia, a company specializing in agentic Retrieval-Augmented Generation (RAG) AI technology. The transaction, signed and closed on June 30, 2025, brings Nuclia’s cloud-native RAG-as-a-service product under Progress’ expanding portfolio of AI-powered infrastructure and digital experience solutions. …
BofA Securities issued a notable downgrade forProKidney Corp. (NASDAQ: PROK)on Monday, shifting its rating fromNeutraltoUnderperformand sharply reducing its price target from USD3.00 to USD1.00 per share. The reassessment follows a combination of revised expectations for ProKidney’s lone therapeutic candidate, REACT, and growing caution regarding …
Market Movers:On Friday, the top gainers were Locafy Limited (+225.49%), followed by Blue Gold Limited (+210.79%). On the contrary CID HoldCo, Inc (-47.23%) Liminatus Pharma, Inc (- 42.89%) declined the most the same day.
Goldman Sachs on Thursday upgraded shares of Affiliated Managers Group, Inc. (NYSE: AMG) fromNeutraltoBuy, assigning a price target of USD218.00. The new target suggests an approximate 17% upside from AMG’s current trading levels near USD199.52, which sits close to the stock’s 52-week high.
Shares of British American Tobacco plc (NYSE:BTI)received an upgrade from Wall Street Zen over the weekend, with the firm lifting its rating from “Hold” to “Buy,” according to a research note issued on Saturday. This adjustment follows a series of recent analyst updates that …
Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company focused on programmed T cell therapies, has announced updated results from its ongoing FELIX trial evaluating obe-cel, an autologous CD19 CAR T-cell therapy, in adults with relapsed or refractory (r/r) CD19-positive B-cell acute lymphoblastic leukemia (B-ALL).
Lemonade Inc. (NYSE: LMND)is a U.S.- and Europe-based insurer offering renters, homeowners, auto, pet, and life insurance through multiple sales channels.
Please wait processing your request...